Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells.

Hershberger, Pamela A

Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells. [electronic resource] - The Journal of steroid biochemistry and molecular biology Aug 2009 - 102-9 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1879-1220

10.1016/j.jsbmb.2009.05.004 doi


Carcinoma, Non-Small-Cell Lung--enzymology
Cell Line, Tumor
Estrogen Receptor beta--agonists
Genistein--pharmacology
Ginsenosides--pharmacology
Humans
Ligands
Lung Neoplasms--enzymology
Mitogen-Activated Protein Kinase 1--genetics
Nitriles--pharmacology
Protein Kinase Inhibitors--pharmacology
Sapogenins--pharmacology
Transcription Factors--genetics
Transcription, Genetic
Transfection